壁报展示

专题首页 » 壁报展示
The Need for a Dynamic Approach to Modelling Disease Progression in Cost-Effectiveness Studies of Antiviral Therapies in Patients with Chronic Hepatitis C 阅读数：1995详细阅读>>
On-Treatment Decline in Serum HBsAg Levels Predicts Sustained Immune Control and HBsAg Clearance 6 Months Post-Treatment in HBeAg-Positive Hepatitis B Virus-Infected Patients Treated with Peginterferon Alfa-2a [40KD] (PEGASYS) 阅读数：2172详细阅读>>
Long-term Efficacy of Entecavir Therapy on Viral Suppression in Nucleoside-na ve 阅读数：1959详细阅读>>
Modelling the impact of treatment with entecavir on long-term mortality，morbidity and healthcare costs of chronic hepatitis B in France 阅读数：2073详细阅读>>
TELBIVUDINE ADD-ON THERAPY FOR A CIRRHOTIC PATIENT WITH CHRONIC HEPATITIS B WHO FAILED SEQUENTIAL TREATMENT WITH LAMIVUDINE AND ADEFOVIR: A CASE REPORT 阅读数：2143详细阅读>>
Baseline characteristics and interim on-treatment responses from the real-world PROPHESYS cohorts inform future treatment paradigms for chronic hepatitis C(CHC) 阅读数：1797详细阅读>>
首页 1 尾页